A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the pharmacokinetic (PK) parameters of teriflunomide after a single oral dose of 14
mg administration in Chinese healthy subjects
Secondary Objective:
To assess the safety and tolerability after a single oral dose of 14 mg teriflunomide in
Chinese healthy subjects